Literature DB >> 31153151

Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.

Güliz Acker1,2,3, Anne Kluge3,4, Mathias Lukas5, Alfredo Conti1,3,6, Diana Pasemann3,4, Franziska Meinert1,3, Phuong Thuy Anh Nguyen1,3, Claudius Jelgersma1,3, Franziska Loebel1,3, Volker Budach3,4, Peter Vajkoczy1,3, Christian Furth5, Alexander D J Baur5, Carolin Senger3,4.   

Abstract

OBJECTIVEFor stereotactic radiosurgery (SRS) planning, precise contouring of tumor boundaries and organs at risk is of utmost importance. Correct interpretation of standard neuroimaging (i.e., CT and MRI) can be challenging after previous surgeries or in cases of skull base lesions with complex shapes. The aim of this study was to evaluate the impact of 68Ga-DOTATOC PET/MRI on treatment planning for image-guided SRS by CyberKnife.METHODSThe authors retrospectively identified 11 meningioma treatments in 10 patients who received a 68Ga-DOTATOC PET/MRI prior to SRS. The planning target volume (PTV) used for the patients' treatment was defined as the reference standard. This was contoured by a treating radiosurgeon (RS0) using fused planning CT and PET/MRI data sets. The same tumors were then contoured by another experienced radiosurgeon (RS1) and by a less-experienced radiosurgeon (RS2), both blinded to PET data sets. A comparison of target volumes with focus on volume-based metrics and distance to critical structures was performed. RS1 and RS2 also filled in a questionnaire analyzing the confidence level and the subjective need for the implementation of PET data sets for contouring.RESULTSAnalysis showed a subjective personal preference for PET/MRI in all cases for both radiosurgeons, particularly in proximity to critical structures. The analysis of the planning volumes per physician showed significantly smaller RS2-PTV in comparison to RS1-PTV and to RS0-PTV, whereas the median volumes were comparable between RS1-PTV and RS2-PTV (median: RS0: 4.3 cm3 [IQR 3.4-6.5 cm3] and RS1: 4.5 cm3 [IQR 2.7-6 cm3] vs RS2: 2.6 cm3 [IQR 2-5 cm3]; p = 0.003). This was also reflected in the best spatial congruency between the 2 experienced physicians (RS0 and RS1). The percentage of the left-out volume contoured by RS1 and RS2 compared to RS0 with PET/MRI demonstrated a relevant left-out-volume portion in both cases with greater extent for the less-experienced radiosurgeon (RS2) (RS1: 19.1% [IQR 8.5%-22%] vs RS2: 40.2% [IQR 34.2%-53%]). No significant differences were detected regarding investigated critical structures.CONCLUSIONSThis study demonstrated a relevant impact of PET/MRI on target volume delineation of meningiomas. The extent was highly dependent on the experience of the treating physician. This preliminary study supports the relevance of 68Ga-DOTATOC PET/MRI as a tool for radiosurgical treatment planning of meningiomas.

Entities:  

Keywords:  68Ga-DOTATOC = gallium-68–labeled [DOTA0-Phe1-Tyr3]octreotide; 68Ga-DOTATOC PET/MRI; CyberKnife; FSRT = fractionated stereotactic radiation therapy; GTV = gross tumor volume; IMRT = intensity-modulated radiotherapy; IQR = interquartile range; MP-RAGE = magnetization-prepared rapid acquisition with gradient echo; OAR = organ at risk; PET = positron emission tomography; PTV = planning target volume; RS = radiosurgeon; SRS = stereotactic radiosurgery; SSTR = somatostatin receptor; meningioma; stereotactic radiosurgery

Year:  2019        PMID: 31153151     DOI: 10.3171/2019.3.FOCUS1925

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  9 in total

1.  The "Combo" radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis.

Authors:  Antonio Pontoriero; Paola Critelli; Alfredo Conti; Salvatore Cardali; Filippo Flavio Angileri; Antonino Germanò; Sara Lillo; Alessandro Carretta; Anna Brogna; Anna Santacaterina; Silvana Parisi; Stefano Pergolizzi
Journal:  J Neurooncol       Date:  2022-08-04       Impact factor: 4.506

2.  Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome.

Authors:  Kerstin A Kessel; Wolfgang Weber; Igor Yakushev; Hanna Fischer; Theresa Voglhuber; Christian Diehl; Christoph Straube; Claus Zimmer; Benedikt Wiestler; Jens Gempt; Bernhard Meyer; Stephanie E Combs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-22       Impact factor: 9.236

3.  Effectiveness and Safety of Robotic Radiosurgery for Optic Nerve Sheath Meningiomas: A Single Institution Series.

Authors:  Carolin Senger; Anne Kluge; Melina Kord; Zoe Zimmermann; Alfredo Conti; Markus Kufeld; Anita Kreimeier; Franziska Loebel; Carmen Stromberger; Volker Budach; Peter Vajkoczy; Gueliz Acker
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

4.  Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition.

Authors:  Josefine Graef; Carolin Senger; Christoph Wetz; Alexander D J Baur; Anne K Kluge; Mathias Lukas; Julian M M Rogasch; Thula C Walter-Rittel; David Kohnert; Marcus Makowski; Güliz Acker; Kai Huang; Volker Budach; Holger Amthauer; Imke Schatka; Christian Furth
Journal:  Diagnostics (Basel)       Date:  2020-12-13

5.  [68Ga]-DOTATATE PET/MRI as an adjunct imaging modality for radiation treatment planning of meningiomas.

Authors:  Sean S Mahase; Diana A Roth O'Brien; Diana No; Michelle Roytman; Myrto E Skafida; Eaton Lin; Nicolas A Karakatsanis; Joseph R Osborne; Andrew Brandmaier; Susan C Pannullo; Rohan Ramakrishna; Philip E Stieg; Jonathan P S Knisely; Jana Ivanidze
Journal:  Neurooncol Adv       Date:  2021-01-21

Review 6.  The Role of [68Ga]Ga-DOTA-SSTR PET Radiotracers in Brain Tumors: A Systematic Review of the Literature and Ongoing Clinical Trials.

Authors:  Paolo Palmisciano; Gina Watanabe; Andie Conching; Christian Ogasawara; Gianluca Ferini; Othman Bin-Alamer; Ali S Haider; Maria Gabriella Sabini; Giacomo Cuttone; Sebastiano Cosentino; Massimo Ippolito; Giuseppe E Umana
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

Review 7.  Somatostatin Receptor Targeted PET-Imaging for Diagnosis, Radiotherapy Planning and Theranostics of Meningiomas: A Systematic Review of the Literature.

Authors:  Luca Filippi; Isabella Palumbo; Oreste Bagni; Orazio Schillaci; Cynthia Aristei; Barbara Palumbo
Journal:  Diagnostics (Basel)       Date:  2022-07-08

Review 8.  Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications.

Authors:  Riccardo Laudicella; Domenico Albano; Salvatore Annunziata; Diletta Calabrò; Giovanni Argiroffi; Elisabetta Abenavoli; Flavia Linguanti; Domenico Albano; Antonio Vento; Antonio Bruno; Pierpaolo Alongi; Matteo Bauckneht
Journal:  Cancers (Basel)       Date:  2019-09-22       Impact factor: 6.639

9.  68Ga-DOTATOC PET/CT Follow Up after Single or Hypofractionated Gamma Knife ICON Radiosurgery for Meningioma Patients.

Authors:  Fabio Barone; Francesco Inserra; Gianluca Scalia; Massimo Ippolito; Sebastiano Cosentino; Antonio Crea; Maria Gabriella Sabini; Lucia Valastro; Iolanda Valeria Patti; Stefania Mele; Grazia Acquaviva; Alessandra Tocco; Maria Tamburo; Francesca Graziano; Ottavio S Tomasi; Rosario Maugeri; Gerardo Iacopino; Salvatore Cicero; Lidia Strigari; Giuseppe Emmanuele Umana
Journal:  Brain Sci       Date:  2021-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.